![Geoffrey Parker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Geoffrey Parker
Director of Finance/CFO at
ALLOGENE THERAPEUTICS, INC.
Net worth: 2 M $ as of 2026-06-29
Profile
Geoffrey M.
Parker is currently an Independent Director at Perrigo Co. Plc since 2016, a Director at Better Therapeutics LLC since 2021, and Chief Financial Officer & Executive Vice President at Allogene Therapeutics, Inc. starting in 2024.
Formerly, Mr. Parker was an Independent Director at ChemoCentryx, Inc. from 2009 to 2022, Independent Director at Sunesis Pharmaceuticals, Inc. from 2016 to 2017, Director at Genoptix, Inc., Independent Director at Genomic Health, Inc. from 2016 to 2019, Independent Director at Better Therapeutics, Inc. from 2021 to 2024, MD & Partner-Investment Banking Division at The Goldman Sachs Group, Inc. from 1997 to 2009, Chief Business Officer at InteKrin Therapeutics, Inc. from 2009 to 2010, Chief Financial Officer & Executive Vice President at Tricida, Inc. from 2020 to 2021, Vice President at Feibusch & Co., Inc. from 1995 to 1997, Chief Financial Officer & Executive Vice President at Anacor Pharmaceuticals LLC in 2015, and Chief Financial Officer & Senior Vice President at Anacor, Inc. from 2012 to 2015.
Education includes undergraduate studies at Dartmouth College and an MBA from Stanford Graduate School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-30 | 535,060 ( 0.16% ) | 1 M $ | 2026-06-29 | |
PERRIGO CO. PLC 0.06% | 2026-06-11 | 76,471 ( 0.06% ) | 794 534 $ | 2026-06-29 |
Geoffrey Parker active positions
| Companies | Position | Start |
|---|---|---|
| PERRIGO COMPANY PLC | Director/Board Member | 2016-11-06 |
| ALLOGENE THERAPEUTICS, INC. | Director of Finance/CFO | 2023-10-15 |
Better Therapeutics LLC
 Better Therapeutics LLC Medical SpecialtiesHealth Technology Develops digital therapeutics for treating cardio-metabolic diseases | Director/Board Member | 2021-03-29 |
Former positions of Geoffrey Parker
| Companies | Position | End |
|---|---|---|
| BETTER THERAPEUTICS, INC. | Director/Board Member | 2024-03-13 |
| CHEMOCENTRYX, INC. | Director/Board Member | 2022-10-19 |
| GENOMIC HEALTH, INC. | Director/Board Member | 2019-11-07 |
| VIRACTA THERAPEUTICS, INC. | Director/Board Member | 2017-12-30 |
| ANACOR PHARMACEUTICALS INC | Director of Finance/CFO | 2015-05-30 |
Training of Geoffrey Parker
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
69
1st degree connections
16
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 16 |
|---|---|
The Goldman Sachs Group, Inc.
 The Goldman Sachs Group, Inc. Investment Banks/BrokersFinance Provides investment banking, asset, wealth management and platform services | Finance |
ChemoCentryx, Inc.
 ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small molecule therapeutics for inflammatory, autoimmune diseases and cancer | Health Technology |
Sunesis Pharmaceuticals, Inc.
 Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology therapeutics for treatment of solid and hematologic cancers | Health Technology |
Genoptix, Inc.
 Genoptix, Inc. Medical/Nursing ServicesHealth Services Provides cancer laboratory testing services | Health Services |
Genomic Health, Inc.
 Genomic Health, Inc. Medical/Nursing ServicesHealth Services Engages in genomic-based diagnostic tests for overtreatment and optimal treatment of early stage cancer | Health Services |
InteKrin Therapeutics, Inc.
 InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for metabolic and immune disorders | Health Technology |
Tricida, Inc.
 Tricida, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparation products | Health Technology |
Feibusch & Co., Inc.
 Feibusch & Co., Inc. Investment ManagersFinance Operates as a venture capital firm | Finance |
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anacor Pharmaceuticals LLC
 Anacor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a bio pharmaceutical company | Health Technology |
Anacor, Inc.
 Anacor, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Perrigo Co. Plc
 Perrigo Co. Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Stanford Graduate School of Business
 Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Allogene Therapeutics, Inc.
 Allogene Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immuno-oncology | Health Technology |
Better Therapeutics LLC
Better Therapeutics LLC Medical SpecialtiesHealth Technology Develops digital therapeutics for treating cardio-metabolic diseases | Health Technology |
Better Therapeutics, Inc.
 Better Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops prescription digital therapeutics for the treatment of cardiovascular and metabolic diseases | Health Technology |
- Stock Market
- Insiders
- Geoffrey Parker
